CRYO ROP PARTICIPATING CENTER--PHASE III

CRYO ROP 参与中心--第三期

基本信息

  • 批准号:
    2430377
  • 负责人:
  • 金额:
    $ 1.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-06-01 至 1998-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Investigator's Abstract) The purpose of the proposed study is to examine the long-term structural and functional effects of cryotherapy as a treatment for severe retinopathy of prematurity (ROP). In the initial phase of the study, eyes with 5 contiguous or 8 total clock hours of stage 3 plus ROP, in 291 infants with birth weights less than 1251 g., were randomized to received cryotherapy or no cryotherapy. Follow-up to age 12 months indicated that cryotherapy reduced the incidence of unfavorable structural outcome by 45.8 percent, and the incidence of unfavorable visual acuity outcome by 37.8 percent. Based on the preliminary data, follow-up to age 42 months during Phase II of the study indicated that cryotherapy reduced the incidence of unfavorable resolution acuity outcome by 21.4 percent, and by 19.7 percent when based on measurement of recognition acuity. The present study proposes to follow patients in the randomized group and a relatively small subgroup (67) of potentially high risk patients from the Natural History study through age 10 years, to determine whether the reduction in benefit of cryotherapy noted between ages 12 and 42 months continues into mid-childhood. Evaluation of the effects of cryotherapy will be based on examination findings in the posterior pole of the eye and on assessment of visual acuity, as in Phase II. In addition, a more complete evaluation of visual function will be conducted at age 9 years, through assessment of monocular contrast sensitivity, monocular color vision, and stereopsis, and at age 10 years, through measurement of the extent of the visual field by Goldmann perimetry.
描述(研究者摘要)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen S. Feman其他文献

Serum angiotensin converting enzyme in diabetic patients.
糖尿病患者血清血管紧张素转换酶。
  • DOI:
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Stephen S. Feman;Robert A. Mericle;George W. Reed;James M. May;Robert J. Workman
  • 通讯作者:
    Robert J. Workman

Stephen S. Feman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen S. Feman', 18)}}的其他基金

CRYO ROP PARTICIPATING CENTER--PHASE III
CRYO ROP 参与中心--第三期
  • 批准号:
    2163524
  • 财政年份:
    1994
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO ROP PARTICIPATING CENTER--PHASE III
CRYO ROP 参与中心--第三期
  • 批准号:
    2163525
  • 财政年份:
    1994
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO ROP PARTICIPATING CENTER--PHASE III
CRYO ROP 参与中心--第三期
  • 批准号:
    2163523
  • 财政年份:
    1994
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO-ROP PARTICIPATING CENTER
CRYO-ROP 参与中心
  • 批准号:
    3551754
  • 财政年份:
    1985
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO-ROP PARTICIPATING CENTER
CRYO-ROP 参与中心
  • 批准号:
    3551752
  • 财政年份:
    1985
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO-ROP PARTICIPATING CENTER
CRYO-ROP 参与中心
  • 批准号:
    3551753
  • 财政年份:
    1985
  • 资助金额:
    $ 1.1万
  • 项目类别:
CRYO-ROP PARTICIPATING CENTER
CRYO-ROP 参与中心
  • 批准号:
    3551755
  • 财政年份:
    1985
  • 资助金额:
    $ 1.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了